ABL has three platform solutions for COVID-19 diagnostic testing:
Early detection of COVID-19 through a qPCR molecular assay (coming soon).
(now available for Research Use Only. Not for use in diagnostic procedures). Click here for a PDF with more details.
Serology: SARS-CoV-2 Antibody Test (More information coming soon.)
ABLDx has submitted an EUA application to the FDA for clinical use of the UltraGene® Combo2Screen SARS-CoV-2 Assay as a test for COVID-19.